Author:
Kalff Jörg C.,Stoffels Burkhard,Enderes Jana
Publisher
Springer Berlin Heidelberg
Reference20 articles.
1. André T, Shiu K-K, Kim TW, Jensen BV, Jensen LH, Punt C et al (2020) Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl J Med 383(23):2207–2218. https://doi.org/10.1056/NEJMoa2017699
2. Bae SH, Park W, Choi DH, Nam H, Kang WK, Park YS et al (2011) Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer. Radiat Oncol 6:52. https://doi.org/10.1186/1748-717X-6-52
3. Collins LK, Goodwin JA, Spencer HJ, Guevara C, Ferrell B, McSweeney J, Badgwell BD (2013) Patient reasoning in palliative surgical oncology. J Surg Oncol 107(4):372–375. https://doi.org/10.1002/jso.23215
4. Cutsem E van, Cervantes A, Adam R, Sobrero A, van Krieken JH, Aderka D et al (2016) ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. In: Ann Oncol 27(8):1386–1422. https://doi.org/10.1093/annonc/mdw235
5. Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF (Leitlinienprogramm Onkologie) (o.J.) S3-Leitlinie Kolorektales Karzinom, Langversion 2.1, 2019. AWMF Registrierungsnummer: 021/007OL. http://www.leitlinienprogramm-onkologie.de/leitlinien/kolorektales-karzinom/. Zugegriffen am 20.10.2022